to identify novel compounds targeting henipavirus replication for pandemic antiviral preparedness

Grant number: INV-048917

Grant search

Key facts

  • Disease

    Unspecified
  • start year

    2022
  • Known Financial Commitments (USD)

    $3,101,691
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    United States of America
  • Lead Research Institution

    University of Illinois at Chicago
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A